tradingkey.logo

Stereotaxis Inc

STXS
View Detailed Chart
2.445USD
+0.105+4.49%
Close 12/22, 16:00ETQuotes delayed by 15 min
222.70MMarket Cap
LossP/E TTM

Stereotaxis Inc

2.445
+0.105+4.49%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.49%

5 Days

+5.39%

1 Month

+5.39%

6 Months

+19.85%

Year to Date

+7.24%

1 Year

+4.04%

View Detailed Chart

TradingKey Stock Score of Stereotaxis Inc

Currency: USD Updated: 2025-12-19

Key Insights

Stereotaxis Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 111/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.25.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stereotaxis Inc's Score

Industry at a Glance

Industry Ranking
111 / 208
Overall Ranking
266 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
4.250
Target Price
+80.08%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Stereotaxis Inc Highlights

StrengthsRisks
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Growing
The company is in a growing phase, with the latest annual income totaling USD 26.92M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 26.92M.
Fairly Valued
The company’s latest PE is -8.30, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 41.68M shares, decreasing 8.77% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 5.27K shares of this stock.

Stereotaxis Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Stereotaxis Inc Info

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Ticker SymbolSTXS
CompanyStereotaxis Inc
CEOFischel (David Leo)
Websitehttps://www.stereotaxis.com/

FAQs

What is the current price of Stereotaxis Inc (STXS)?

The current price of Stereotaxis Inc (STXS) is 2.445.

What is the symbol of Stereotaxis Inc?

The ticker symbol of Stereotaxis Inc is STXS.

What is the 52-week high of Stereotaxis Inc?

The 52-week high of Stereotaxis Inc is 3.590.

What is the 52-week low of Stereotaxis Inc?

The 52-week low of Stereotaxis Inc is 1.540.

What is the market capitalization of Stereotaxis Inc?

The market capitalization of Stereotaxis Inc is 222.70M.

What is the net income of Stereotaxis Inc?

The net income of Stereotaxis Inc is -25.35M.

Is Stereotaxis Inc (STXS) currently rated as Buy, Hold, or Sell?

According to analysts, Stereotaxis Inc (STXS) has an overall rating of Buy, with a price target of 4.250.

What is the Earnings Per Share (EPS TTM) of Stereotaxis Inc (STXS)?

The Earnings Per Share (EPS TTM) of Stereotaxis Inc (STXS) is -0.282.
KeyAI